Elevated risk of colorectal adenoma with Helicobacter pylori‐related chronic gastritis: A population‐based case‐control study

This study investigated correlations between Helicobacter pylori infection or chronic atrophic gastritis (CAG) and risk of colorectal adenoma in a population‐based case‐control study. Subjects comprised asymptomatic, middle‐aged, male Japanese factory workers who participated in an annual health check‐up program, including cancer screening with colonoscopy. We selected 239 colorectal adenoma cases based on histological evaluation and 239 age‐matched adenoma‐free controls, and evaluated colorectal adenoma risk according to stage of H. pylori‐related chronic gastritis as determined by serum tests for H. pylori antibody titer and pepsinogen. Subjects with colorectal adenoma were more likely to be smokers and have hypercholesterolemia. H. pylori infection was a risk factor for adenoma as a whole (crude odds ratio [OR]: 2.26, 95% confidence interval [CI]: 1.44–3.55). Analysis of distal adenoma cases showed that adenoma risk was significantly increased in the presence of H. pylori infection, but there was no further increase in risk with CAG. In contrast, proximal adenoma risk increased stepwise with the presence and progression of H. pylori‐related chronic gastritis and showed a maximal and significant increase with CAG (crude OR: 4.51, 95% CI: 1.43–14.2). Subjects with more extensive and severe gastritis showed still higher risk not only for proximal but also for distal adenoma. H. pylori‐related chronic gastritis is likely to be involved in the development of colorectal neoplasms, and its progression appears to increase the risk, particularly for proximal adenomas. Knowing the H. pylori‐related chronic gastritis stage will probably be useful for evaluation of risk for colorectal neoplasia.

[1]  S. Akimoto,et al.  Gastric acid reduction leads to an alteration in lower intestinal microflora. , 2009, Biochemical and biophysical research communications.

[2]  B. Eom,et al.  Synchronous and metachronous cancers in patients with gastric cancer , 2008, Journal of surgical oncology.

[3]  N. Yoshimura,et al.  Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males , 2008, Cancer Epidemiology Biomarkers & Prevention.

[4]  M. Inoue,et al.  Atrophic Gastritis, Helicobacter pylori, and Colorectal Cancer Risk: A Case‐Control Study , 2007, Helicobacter.

[5]  J. Tharakan,et al.  Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? , 2007, World journal of surgical oncology.

[6]  A. Mentis,et al.  Hypergastrinemia Is Associated with Increased Risk of Distal Colon Adenomas , 2006, Digestion.

[7]  I. Choi,et al.  Gastric cancer patients at high-risk of having synchronous cancer. , 2006, World journal of gastroenterology.

[8]  T. Yoshikawa,et al.  Helicobacter pylori infection is associated with colon adenomatous polyps detected by high‐resolution colonoscopy , 2005, International journal of cancer.

[9]  T. Tajiri,et al.  Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women , 2005, Journal of Gastroenterology.

[10]  L. Tao,et al.  DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon. , 2004, Cancer letters.

[11]  G. Baldwin,et al.  Gastrins, cholecystokinins and gastrointestinal cancer. , 2004, Biochimica et biophysica acta.

[12]  N. Yoshimura,et al.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer , 2004, International journal of cancer.

[13]  B. Iacopetta Are there two sides to colorectal cancer? , 2002, International journal of cancer.

[14]  K. Borch,et al.  Diagnosis of gastritis by means of a combination of serological analyses. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[15]  A. Sigurdsson,et al.  The long term results of endoscopic surveillance of premalignant gastric lesions , 2002, Gut.

[16]  S. Pitlik,et al.  Relationship between Helicobacter pylori CagA status and colorectal cancer , 2001, American Journal of Gastroenterology.

[17]  M. Szyf,et al.  Interleukin-6 Regulation of the Human DNA Methyltransferase (HDNMT) Gene in Human Erythroleukemia Cells* , 2001, The Journal of Biological Chemistry.

[18]  K. Uchida,et al.  Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. , 2001, Cancer research.

[19]  Y. Tsubono,et al.  Screening for gastric cancer in Japan , 2000, Gastric Cancer.

[20]  P. Pieniążek,et al.  Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. , 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[21]  K. Kanazawa,et al.  Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  B. Rump,et al.  Helicobacter pylori and the Risk of Colonic Adenomas , 1999, Digestion.

[23]  P. Rutgeerts,et al.  Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy , 1998, Alimentary pharmacology & therapeutics.

[24]  G. Friedman,et al.  Gastrin and colorectal cancer: a prospective study. , 1998, Gastroenterology.

[25]  R. Franchis,et al.  High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. , 1997, Journal of clinical gastroenterology.

[26]  G. Brandi,et al.  Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia , 1997, Gut.

[27]  S. D. Lee,et al.  Serodiagnosis of Helicobacter pylori infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results , 1997, Journal of clinical microbiology.

[28]  A. Blum,et al.  Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. , 1996, Gut.

[29]  M. Rugge,et al.  Helicobacter pylori serology in patients with chronic gastritis. , 1996, The American journal of gastroenterology.

[30]  G. Ciccotosto,et al.  Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. , 1995, Gastroenterology.

[31]  W E Moore,et al.  Intestinal floras of populations that have a high risk of colon cancer , 1995, Applied and environmental microbiology.

[32]  E. El-Omar,et al.  Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. , 1994, Gastroenterology.

[33]  G. Colditz,et al.  A meta-analysis of cholecystectomy and risk of colorectal cancer. , 1993, Gastroenterology.

[34]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[35]  W. J. Visek,et al.  Effects of ammonium acetate and sodium cholate on N-methyl-N'-nitro-N-nitrosoguanidine-induced colon carcinogenesis of rats. , 1988, Cancer research.

[36]  Kenji Takahashi,et al.  Serum pepsinogens as a screening test of extensive chronic gastritis , 1987, Gastroenterologia Japonica.

[37]  R. Hunt,et al.  Relationship between gastric secretion and infection. , 1987, Gut.

[38]  K. Miki,et al.  Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[39]  W. J. Visek,et al.  Diet and cell growth modulation by ammonia. , 1978, The American journal of clinical nutrition.

[40]  T. Ushijima,et al.  DNA methylation: a marker for carcinogen exposure and cancer risk , 2008, Environmental health and preventive medicine.

[41]  F. Hernández-Navarro,et al.  [Megaloblastic anemia]. , 2006, Medicina clinica.

[42]  H. Bernstein,et al.  Bile acids as carcinogens in human gastrointestinal cancers. , 2005, Mutation research.

[43]  Y. Kopelman,et al.  Helicobacter pylori: seroprevalence and colorectal cancer. , 2000, The Israel Medical Association journal : IMAJ.

[44]  K. Shinchi,et al.  Prevalence of colorectal adenomas in a healthy Japanese middle-aged male population. , 1998, Scandinavian journal of gastroenterology.

[45]  M. Matsushima,et al.  Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method. , 1995, Advances in experimental medicine and biology.

[46]  H. Leveen,et al.  Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[47]  E. Shemesh,et al.  Is there an association between gastric polyps and colonic neoplasms? , 1989, Digestion.

[48]  J. Aarbakke,et al.  Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome. , 1976, Scandinavian journal of gastroenterology.

[49]  B. Drasar,et al.  Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. , 1969, Gastroenterology.

[50]  R. C. Connelly Atrophic gastritis. , 1949, Journal - Michigan State Medical Society.